Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$101K Sell
10,194
-517
-5% -$5.38K ﹤0.01% 743
2023
Q2
$107K Sell
10,711
-1,159
-10% -$11.1K ﹤0.01% 748
2023
Q1
$114K Buy
+11,870
New +$132K ﹤0.01% 762
2022
Q3
Sell
-10,755
Closed -$113K 833
2022
Q2
$113K Sell
10,755
-900
-8% -$9.87K ﹤0.01% 794
2022
Q1
$127K Buy
+11,655
New +$154K ﹤0.01% 821
2021
Q4
Sell
-10,492
Closed -$142K 863
2021
Q3
$142K Buy
+10,492
New +$149K ﹤0.01% 811
2021
Q2
Sell
-84,246
Closed -$1.18M 804
2021
Q1
$1.18M Buy
+84,246
New +$1.37M 0.02% 374
2016
Q1
Sell
-100
Closed -$5K 641
2015
Q4
$5K Hold
100
﹤0.01% 664
2015
Q3
$4K Sell
100
-142
-59% -$7.92K ﹤0.01% 718
2015
Q2
$16K Hold
242
﹤0.01% 559
2015
Q1
$14K Hold
242
﹤0.01% 532
2014
Q4
$14K Hold
242
﹤0.01% 549
2014
Q3
$11K Hold
242
﹤0.01% 587
2014
Q2
$12K Hold
242
﹤0.01% 491
2014
Q1
$12K Hold
242
﹤0.01% 522
2013
Q4
$11K Buy
+242
New +$9.95K ﹤0.01% 482

Other funds holding VTRS

Colony Group's VTRS Position: Q3 2023 in Review

Colony Group reduced its Viatris (VTRS) stake by 4.8% in Q3 2023, selling an estimated $5.38K and leaving 10,194 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #743.

Colony Group first reported a position in VTRS in Q4 2013 and has held it in 16 quarters since. The position peaked at $1.18M in Q1 2021. 960 funds tracked by Wall St. Rank hold VTRS as of Q3 2023.

  • Colony Group held 10,194 shares of Viatris worth $101K as of Q3 2023.
  • Colony Group sold 517 Viatris shares in Q3 2023, an estimated $5.38K.
  • Viatris made up ﹤0.01% of Colony Group's portfolio in Q3 2023, its #743 holding.
  • Colony Group first reported a position in Viatris in Q4 2013 and has held it in 16 quarters since.
  • Colony Group's Viatris position peaked at $1.18M in Q1 2021.
  • 960 funds tracked by Wall St. Rank held Viatris as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.